Barclays’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $381K | Sell |
5,300
-105,400
| -95% | -$8.12M | ﹤0.01% | 3344 |
|
|
2025
Q4 | $8.79M | Sell |
110,700
-608,400
| -85% | -$48M | ﹤0.01% | 1774 |
|
|
2025
Q3 | $54.2M | Buy |
719,100
+130,900
| +22% | +$8.97M | 0.01% | 730 |
|
|
2025
Q2 | $40.6M | Buy |
588,200
+214,700
| +57% | +$14.1M | 0.01% | 797 |
|
|
2025
Q1 | $25.3M | Sell |
373,500
-181,700
| -33% | -$10.9M | 0.01% | 909 |
|
|
2024
Q4 | $24.9M | Buy |
555,200
+105,100
| +23% | +$5.9M | 0.01% | 1001 |
|
|
2024
Q3 | $28.3M | Buy |
+450,100
| New | +$26.3M | 0.01% | 902 |
|
|
2024
Q2 | – | Sell |
-359,800
| Closed | -$28.7M | – | 4953 |
|
|
2024
Q1 | $28.7M | Sell |
359,800
-285,500
| -44% | -$21.8M | 0.01% | 840 |
|
|
2023
Q4 | $51M | Sell |
645,300
-87,100
| -12% | -$6.2M | 0.02% | 656 |
|
|
2023
Q3 | $51.1M | Buy |
+732,400
| New | +$51.9M | 0.03% | 482 |
|
|
2023
Q1 | – | Sell |
-26,000
| Closed | -$2.42M | – | 5136 |
|
|
2022
Q4 | $2.42M | Buy |
+26,000
| New | +$2.51M | ﹤0.01% | 2127 |
|
|
2022
Q1 | – | Sell |
-120,400
| Closed | -$12.4M | – | 5063 |
|
|
2021
Q4 | $12.4M | Sell |
120,400
-53,200
| -31% | -$4.92M | ﹤0.01% | 1157 |
|
|
2021
Q3 | $14.7M | Buy |
173,600
+80,000
| +85% | +$6.7M | 0.01% | 1015 |
|
|
2021
Q2 | $7.81M | Buy |
93,600
+80,000
| +588% | +$6.55M | ﹤0.01% | 1324 |
|
|
2021
Q1 | $1.02M | Sell |
13,600
-785,226
| -98% | -$57.2M | ﹤0.01% | 2761 |
|
|
2020
Q4 | $54.6M | Buy |
798,826
+276,400
| +53% | +$18M | 0.03% | 439 |
|
|
2020
Q3 | $30.5M | Sell |
522,426
-1,800
| -0.3% | -$112K | 0.02% | 562 |
|
|
2020
Q2 | $34.1M | Sell |
524,226
-48,700
| -9% | -$3.07M | 0.03% | 437 |
|
|
2020
Q1 | $34M | Sell |
572,926
-200,272
| -26% | -$13.4M | 0.03% | 434 |
|
|
2019
Q4 | $57.4M | Buy |
773,198
+208,000
| +37% | +$14.6M | 0.03% | 443 |
|
|
2019
Q3 | $35.6M | Sell |
565,198
-2,151,249
| -79% | -$127M | 0.02% | 587 |
|
|
2019
Q2 | $148M | Sell |
2,716,447
-286,450
| -10% | -$15.4M | 0.09% | 182 |
|
|
2019
Q1 | $162M | Buy |
3,002,897
+2,618,436
| +681% | +$162M | 0.11% | 146 |
|
|
2018
Q4 | $25.2M | Buy |
384,461
+166,861
| +77% | +$12.5M | 0.02% | 644 |
|
|
2018
Q3 | $17.1M | Sell |
217,600
-192,200
| -47% | -$13.7M | 0.01% | 942 |
|
|
2018
Q2 | $26.4M | Buy |
409,800
+243,200
| +146% | +$16M | 0.02% | 645 |
|
|
2018
Q1 | $10.4M | Sell |
166,600
-27,800
| -14% | -$1.99M | 0.01% | 1160 |
|
|
2017
Q4 | $14.1M | Buy |
194,400
+56,300
| +41% | +$4.09M | 0.01% | 998 |
|
|
2017
Q3 | $11.2M | Sell |
138,100
-373,700
| -73% | -$29.6M | 0.01% | 981 |
|
|
2017
Q2 | $41.2M | Buy |
511,800
+29,500
| +6% | +$2.33M | 0.04% | 338 |
|
|
2017
Q1 | $37.9M | Sell |
482,300
-39,100
| -7% | -$3.12M | 0.04% | 331 |
|
|
2016
Q4 | $41.1M | Buy |
521,400
+283,500
| +119% | +$22.9M | 0.04% | 325 |
|
|
2016
Q3 | $21.2M | Sell |
237,900
-13,500
| -5% | -$1.27M | 0.02% | 528 |
|
|
2016
Q2 | $24.1M | Buy |
251,400
+47,300
| +23% | +$4.71M | 0.03% | 456 |
|
|
2016
Q1 | $21M | Sell |
204,100
-8,000
| -4% | -$778K | 0.03% | 460 |
|
|
2015
Q4 | $20.6M | Buy |
212,100
+44,100
| +26% | +$4.32M | 0.03% | 561 |
|
|
2015
Q3 | $16.1M | Buy |
168,000
+7,400
| +5% | +$778K | 0.02% | 696 |
|
|
2015
Q2 | $16.7M | Buy |
160,600
+114,700
| +250% | +$11.7M | 0.02% | 748 |
|
|
2015
Q1 | $4.73M | Sell |
45,900
-142,600
| -76% | -$14.4M | 0.01% | 1605 |
|
|
2014
Q4 | $18.1M | Sell |
188,500
-216,300
| -53% | -$19.1M | 0.02% | 811 |
|
|
2014
Q3 | $32M | Buy |
404,800
+283,200
| +233% | +$22.3M | 0.03% | 506 |
|
|
2014
Q2 | $9.12M | Buy |
121,600
+3,000
| +3% | +$227K | 0.01% | 1228 |
|
|
2014
Q1 | $8.78M | Sell |
118,600
-62,700
| -35% | -$4.43M | 0.01% | 1241 |
|
|
2013
Q4 | $12.9M | Sell |
181,300
-21,500
| -11% | -$1.38M | 0.01% | 1067 |
|
|
2013
Q3 | $11.4M | Sell |
202,800
-23,600
| -10% | -$1.41M | 0.01% | 1053 |
|
|
2013
Q2 | $12.9M | Buy |
+226,400
| New | +$13.1M | 0.02% | 892 |
|
Other funds holding CVS
VCM
VPM
Barclays's CVS Position: Q1 2026 in Review
Barclays increased its CVS Health (CVS) stake by 1.1% in Q1 2026, buying an estimated $2.39M and bringing the position to 2,761,283 shares worth $198M. The position accounts for 0.05% of the portfolio, ranked #295.
Barclays first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $526M in Q1 2017. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Barclays held 2,761,283 shares of CVS Health worth $198M as of Q1 2026.
- Barclays bought 31,056 CVS Health shares in Q1 2026, an estimated $2.39M.
- CVS Health made up 0.05% of Barclays's portfolio in Q1 2026, its #295 holding.
- Barclays first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Barclays's CVS Health position peaked at $526M in Q1 2017.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.